Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis

References

• Zhang X, Zou M, Zhang C, et al. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: a prospective study. Eur J Radiol. 2014;83(9):1607–1611.
   PubMed Web of Science ®Google Scholar
• Garavaglia E, Audrey S, Annalisa I, et al. Adenomyosis and its impact on women fertility. Int J Reprod Biomed. 2015;13:327–336.
   Web of Science ®Google Scholar
• Zhu L, Chen S, Che X, et al. Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosisvia laparotomy versus laparoscopy: a long-term result in a single institution. JPR. 2019;12:1917–1924.
   Web of Science ®Google Scholar
• Meridith J. Englander.Uterine artery embolization for the treatment of adenomyosis. Semin Intervent Radiol. 2008;25(4):387–393.
   PubMedGoogle Scholar
• Levgur M. Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet. 2007;276(1):1–15.
   PubMedGoogle Scholar
• Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Res. 2016;5(2):186–129.
   Google Scholar
• Vercellini P, Vigano P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
   PubMed Web of Science ®Google Scholar
• Pontis A, D'Alterio MN, Pirarba S, et al. C. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32(9):696–700.
   PubMed Web of Science ®Google Scholar
• Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32(5):496–503.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li K, Xie B, et al. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynaecol Obstet. 2014;124(3):207–211.
   PubMed Web of Science ®Google Scholar
• Zhou CY, Xu XJ, He J. Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation. Zhonghua Fu Chan Ke Za Zhi. 2016;51:845–849.
   PubMedGoogle Scholar
• Jaeyoon P, Seong LJ, Jae-Hwan C, et al. Effects of highintensity-focused ultrasound treatment on benign uterine tumor. J Korean Med Sci. 2016;31:1279–1283.
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Chen W, et al. Safety of ultrasoundguided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–145.
   PubMed Web of Science ®Google Scholar
• Zhang L, RaoF, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand. 2017;96(6):707–714.
   PubMed Web of Science ®Google Scholar
• Jingqi W, Lu Z, Jun Z, et al. Clinical usefulness of the microbubble contrast agent SonoVue in enhancing the effects of High-Intensity focused ultrasound for the treatment of adenomyosis. J Ultrasound Med. 2018;37(12):2811–2819.
   PubMed Web of Science ®Google Scholar
• Cheng C-Q, Zhang R-T, Xiong Y, et al. Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety. Medicine. 2015;94(16):e729.
   PubMed Web of Science ®Google Scholar
• Li Q, Xiao YB, Liang ZG, et al. Ablation of leiomyomas using a combination of HIFU and iodized oil in vitro. Ultrasound Med Biol. 2012;38(9):1576–1581.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Y, Zhang R, et al. A case-control study of high-intensity focused ultrasound combined with sonographically guided intratumoral ethanol injection in the treatment of uterine fibroids. J Ultrasound Med. 2014;33(4):657–665.
   PubMed Web of Science ®Google Scholar
• Peng S, Xiong Y, Li K, et al. Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol. 2012;81(12):3832–3838.
   PubMed Web of Science ®Google Scholar
• Chung DJ, Cho SH, Lee JM, et al. Effect of microbubble contrast agent during high intensity focused ultrasound ablation on rabbit liver in vivo. Eur J Radiol. 2012;81(4):e519–e523.
   PubMed Web of Science ®Google Scholar
• Luo W, Zhou X, Ren X, et al. Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high intensity focused ultrasound ablation in rabbit livers in vivo. J Ultrasound Med. 2007;26(4):469–476.
   PubMed Web of Science ®Google Scholar
• Otonkoski S, Sainio T, Komar G, et al. Oxytocin selectively reduces blood flow in uterine fibroids without an effect on myometrial blood flow: a dynamic contrast enhanced MRI evaluation. Int J Hyperthermia. 2020;37(1):1293–1300.
   PubMed Web of Science ®Google Scholar
• Yu SC, Cheung EC, Leung VY, et al. Oxytocin-augmented and non-sedating high-intensity-focused ultrasound (HIFU) for uterine fibroids showed promising outcome as compared To HIFU alone or uterine artery embolization. Ultrasound Med Biol. 2019;45(12):3207–3213.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in High-Intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:7518026.
   PubMed Web of Science ®Google Scholar
• Wang CJ, Lee CL, Yuen LT, et al. Oxytocin infusion in laparoscopic myomectomymay decrease operative blood loss. J Minim Invasive Gynecol. 2007;14(2):184–188.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Han ZY, Zhang J, et al. A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids. Eur J Radiol. 2015;84(3):413–417.
   PubMed Web of Science ®Google Scholar
• Fan H-J, Cun J-P, Zhao W, et al. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis. Int J Hyperthermia. 2018;35(1):534–540.
   PubMed Web of Science ®Google Scholar
• Peng S, Hu L, Chen W, et al. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids. Ultrasonics. 2015;58:123–128.
   PubMed Web of Science ®Google Scholar
• Moyer LC, Timbie KF, Sheeran PS, et al. High-intensity focused ultrasound ablation enhancement in vivo via phase-shift nanodroplets compared to microbubbles. J Ther Ultrasound. 2015;3:7.
   PubMedGoogle Scholar
• Hamano N, Negishi Y, Takatori K, et al. Combination of bubble liposomes and high-intensity focused ultrasound (HIFU) enhanced antitumor effect by tumor ablation. Biol Pharm Bull. 2014;37(1):174–177.
   PubMed Web of Science ®Google Scholar
• Zhou D, Wang Z, Sun Y, et al. Superparamagnetic PLGA-iron oxide microspheres as contrast agents for dual-imaging and enhance the effects of high intensity focused ultrasound ablation on liver tissue. RSC Adv. 2015;5(45):35693–35703.
   Web of Science ®Google Scholar
• Jiang N, Xie B, Zhang X, et al. Enhancing ablation effects of a microbubble-enhancing contrast agent (“SonoVue”) in the treat ment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial. Cardiovasc Intervent Radiol. 2014;37(5):1321–1328.
   PubMed Web of Science ®Google Scholar
• Isern J, Pessarrodona A, Rodriguez J, et al. Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids. Ultrason Sonochem. 2015;27:688–693.
   PubMed Web of Science ®Google Scholar
• Roach MK, Abramovici A, Tita AT. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. Am J Perinatol. 2013;30(7):523–528.
   PubMed Web of Science ®Google Scholar
• Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol. 2011;24(3):255–261.
   PubMed Web of Science ®Google Scholar
• Richter ON, Kubler K, Schmolling J, et al. Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri. Mol Hum Reprod. 2004;10(5):339–346.
   PubMed Web of Science ®Google Scholar
• Loddenkemper C, Mechsner S, Foss H-D, et al. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol. 2003;27(11):1458–1462.
   PubMed Web of Science ®Google Scholar
• Mechsner S, Bartley J, Loddenkemper C, et al. Oxytocin receptor expression in smooth muscle cells of perineal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril. 2005;83(4):1220–1231.
   PubMed Web of Science ®Google Scholar